Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Kimmel Cancer Center's immunological disease therapy progress

Jan. 10, 1997

Korean researchers report new immunosuppressant from natural source

Jan. 10, 1997

SKB/WRAIR malaria vaccine shown effective in clinical challenge trial

Jan. 9, 1997

Ciclosporin bioequivalency established

Jan. 9, 1997

Novel antitumor/immunomodulatory agents isolated by Japanese investigators

Jan. 9, 1997

IAF BioVac vaccine R&D in review

Jan. 8, 1997

Allervax Cat moves towards commercialization

Jan. 8, 1997

SangStat files for U.S. marketing approval of Thymoglobulin

Jan. 7, 1997

New AIDS vaccine candidates reported by Institut Pasteur

Jan. 3, 1997

Immunomodulatory effects of ranitidine assessed in patient studies

Jan. 2, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...